Sfoglia per AUTORE
DE ROSSI N
Collezione AOU San Luigi di Orbassano

  

Items : 9

Predicted Expenditure for Prescription Drugs for Multiple Sclerosis in the Italian Market Between 2023 and 2028: Results of the Oracle Project. in Neurology and therapy / Neurol Ther. 2024 Oct;13(5):1415-1430. doi: 10.1007/s40120-024-00644-3. Epub 2024 Aug 2.
2024
AOU San Luigi di Orbassano

Paolicelli D; Borriello G; Clerici R; Colombo E; Croce D; D'Amico E; De Rossi N; Di Sapio A; Fenu G; Maimone D; Marfia GA; Moccia M; Perini P; Piscaglia MG; Razzolini L; Riccaboni M; Signoriello E; Agostoni G; Farina A; Mondino M; Berruto F; Tettamanti A; Donnaloja F; Tortorella C;

A multiparametric score for assessing the individual risk of severe Covid-19 among patients with Multiple Sclerosis. in Multiple sclerosis and related disorders / Mult Scler Relat Disord. 2022 Jul;63:103909. doi: 10.1016/j.msard.2022.103909. Epub 2022 May 25.
2022
AOU San Luigi di Orbassano

Ponzano M; Schiavetti I; Bovis F; Landi D; Carmisciano L; De Rossi N; Cordioli C; Moiola L; Radaelli M; Immovilli P; Capobianco M; Bragadin MM; Cocco E; Scandellari C; Cavalla P; Pesci I; Confalonieri P; Perini P; Bergamaschi R; Inglese M; Petracca M; Trojano M; Tedeschi G; Comi G; Battaglia MA; Patti F; Fragoso YD; Sen S; Siva A; et alii...

COVID-19 Severity in Multiple Sclerosis: Putting Data Into Context. in Neurology(R) neuroimmunology & neuroinflammation / Neurol Neuroimmunol Neuroinflamm. 2021 Nov 9;9(1):e1105. doi: 10.1212/NXI.0000000000001105. Print 20
2022
AOU San Luigi di Orbassano

Sormani MP; Schiavetti I; Carmisciano L; Cordioli C; Filippi M; Radaelli M; Immovilli P; Capobianco M; De Rossi N; Brichetto G; Cocco E; Scandellari C; Cavalla P; Pesci I; Zito A; Confalonieri P; Marfia GA; Perini P; Inglese M; Trojano M; Brescia Morra V; Tedeschi G; Comi G; Battaglia MA; Patti F; Salvetti M; Sormani MP; Schiavetti I; Carmisciano L; et alii...

The effect of air pollution on COVID-19 severity in a sample of patients with multiple sclerosis. in European journal of neurology / Eur J Neurol. 2022 Feb;29(2):535-542. doi: 10.1111/ene.15167. Epub 2021 Nov 15.
2022
AOU San Luigi di Orbassano

Tedeschi G; Pisoni E; Brescia Morra V; Trojano M; Inglese M; Perini P; Marfia GA; Confalonieri P; Zito A; Cavalla P; Pesci I; Scandellari C; Cocco E; Brichetto G; De Rossi N; Capobianco M; Immovilli P; Radaelli M; Filippi M; Carmisciano L; Cordioli C; Schiavetti I; Ponzano M; Bergamaschi R; Comi G; Battaglia MA; Patti F; Salvetti M; Sormani MP; et alii...

Signs and symptoms of COVID-19 in patients with multiple sclerosis. in European journal of neurology / Eur J Neurol. 2022 Dec;29(12):3728-3736. doi: 10.1111/ene.15554. Epub 2022 Sep 23.
2022
AOU San Luigi di Orbassano

Schiavetti I; Carmisciano L; Ponzano M; Cordioli C; Cocco E; Marfia GA; Inglese M; Filippi M; Radaelli M; Bergamaschi R; Immovilli P; Capobianco M; De Rossi N; Brichetto G; Scandellari C; Cavalla P; Pesci I; Confalonieri P; Perini P; Trojano M; Lanzillo R; Tedeschi G; Comi G; Battaglia MA; Patti F; Salvetti M; Sormani MP;

DMTs and Covid-19 severity in MS: a pooled analysis from Italy and France. in Annals of clinical and translational neurology / Ann Clin Transl Neurol. 2021 Aug;8(8):1738-1744. doi: 10.1002/acn3.51408. Epub 2021 Jul 7.
2021
AOU San Luigi di Orbassano

Sormani MP; Salvetti M; Labauge P; Schiavetti I; Zephir H; Carmisciano L; Bensa C; De Rossi N; Pelletier J; Cordioli C; Vukusic S; Moiola L; Kerschen P; Radaelli M; Théaudin M; Immovilli P; Casez O; Capobianco M; Ciron J; Trojano M; Stankoff B; Créange A; Tedeschi G; Clavelou P; Comi G; Thouvenot E; Battaglia MA; Moreau T; Patti F; et alii...

Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis. in Annals of neurology / Ann Neurol. 2021 Apr;89(4):780-789. doi: 10.1002/ana.26028. Epub 2021 Feb 9.
2021
AOU San Luigi di Orbassano

Sormani MP; De Rossi N; Schiavetti I; Carmisciano L; Cordioli C; Moiola L; Radaelli M; Immovilli P; Capobianco M; Trojano M; Zaratin P; Tedeschi G; Comi G; Battaglia MA; Patti F; Salvetti M;

Corrigendum to "Is maraviroc useful in multiple sclerosis patients with natalizumab-related progressive multifocal leukoencephalopathy?" [J. Neurol. Sci. 378 (2017) 233-237]. in Journal of the neurological sciences / J Neurol Sci. 2017 Sep 15;380:19. doi: 10.1016/j.jns.2017.06.037. Epub 2017 Jul 4.
2017
AOU San Luigi di Orbassano
AOU Novara

Gerevini S; Imberti L; Naldi P; Moiola L; Capobianco M; Lugaresi A; De Rossi N; Mancinelli CR; Prosperini L; Scarpazza C; Capra R;

Is maraviroc useful in multiple sclerosis patients with natalizumab-related progressive multifocal leukoencephalopathy? in Journal of the neurological sciences / J Neurol Sci. 2017 Jul 15;378:233-237. doi: 10.1016/j.jns.2017.05.018. Epub 2017 May 12.
2017
AOU San Luigi di Orbassano
AOU Novara

Gerevini S; Imberti L; Naldi P; Moiola L; Capobianco M; Lugaresi A; De Rossi N; Mancinelli CR; Prosperini L; Scarpazza C; Capra R;